Triamterene and Hydrochlorothiazide
- Product NDC
- 10544-537
- 11-digit product format
- 105440537
- Labeler code
- 10544
- Product ID
- 10544-537_11a7210e-67ae-67ac-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Blenheim Pharmacal, Inc.
- Application
- ANDA071851
- Marketing category
- ANDA
- Marketing start
- 2010-06-07
- Marketing end
- 0000-00-00
- Substance
- TRIAMTERENE; HYDROCHLOROTHIAZIDE
- Active strength
- 75 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10544-537-30 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| TRIAMTERENE | ACTIVE INGREDIENT | WS821Z52LQ | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| TRIAMTERENE | ACTIVE MOIETY | WS821Z52LQ | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| POLACRILIN POTASSIUM | INACTIVE INGREDIENT | 0BZ5A00FQU | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| POLYETHYLENE GLYCOL 8000 | INACTIVE INGREDIENT | Q662QK8M3B | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10544-537 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | Legacy NDC, 1 package rows | 20150319_11a76fc1-5a1e-0509-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10544-537-30 | 10544053730 | 30 in 1 BOTTLE, PLASTIC | Historical |